G. Xu
Impact in
- Gastroenterology top 10%
- Gastroesophageal reflux and treatments
- Gastrointestinal motility and disorders
-
- Helicobacter pylori-related gastroenterology studies
- Eosinophilic Esophagitis
- Esophageal Cancer Research and Treatment
Papers in
- Oncology 5
- Cancer-related Molecular Pathways 2
- Colorectal Cancer Treatments and Studies 1
-
- Immune Cell Function and Interaction 2
- Co-authors
- Yongzhao Yao (1 shared paper)Xiaobei Zhan (1 shared paper)Wenjun Zhang (1 shared paper)Yiqi Du (1 shared paper)Zhangdong Jin (1 shared paper)Fei Liu (1 shared paper)Yu Bai (1 shared paper)Jun Gao (1 shared paper)
- Journals
- American Journal of Reproductive Immunology (1 paper)Frontiers in Oncology (1 paper)Gut (1 paper)Journal of Molecular Histology (1 paper)International Journal of Oncology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
G. Xu
10 papers receiving 99 citations
Peers
Comparison fields: 5 of 39
- Gastroenterology 34
- Surgery 57
- Hematology 13
- Transplantation 3
- Health Informatics 1
Countries citing papers authored by G. Xu
This map shows the geographic impact of G. Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Xu more than expected).
Fields of papers citing papers by G. Xu
This network shows the impact of papers produced by G. Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Xu. The network helps show where G. Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 58 | |
| 2 | 2018 | 14 | |
| 3 | 2020 | 6 | |
| 4 | 2022 | 6 | |
| 5 | [The immune effects of rituximab on dendritic cells derived from patients with primary immune thrombocytopenia]. | 2012 | 5 |
| 6 | 2022 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 1995 | 2 | |
| 10 | 2024 | 1 |
About G. Xu
G. Xu is a scholar working on Oncology, Immunology, Hematology, Surgery and Molecular Biology, having authored 10 papers that have together received 99 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Immune Cell Function and Interaction (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Blood groups and transfusion (1 paper). The work is most often cited by research in Gastroenterology (34 citations), Surgery (57 citations), Hematology (13 citations), Transplantation (3 citations) and Health Informatics (1 citation). G. Xu has collaborated with scholars based in China and United States. Frequent co-authors include Yongzhao Yao, Xiaobei Zhan, Wenjun Zhang, Yiqi Du, Zhangdong Jin, Fei Liu, Yu Bai, Jun Gao, Richard Wu and Meiyu Zhou. Their work appears in journals such as American Journal of Reproductive Immunology, Frontiers in Oncology, Gut, Journal of Molecular Histology and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.